Clinical Trials Logo
  1. Home
  2. Vascular Malformations
  3. NCT06189092

Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational Study — BESVAM  

Vascular Malformations Clinical Trial

Official title:
Trattamento Delle Malformazioni Venose a Basso Flusso Con l'Elettroscleroterapia. Studio Osservazionale Prospettico

Clinical Trial Summary

Venous malformations (MVs) are congenital abnormalities of the central or periphery caused by developmental errors at different stages of embryogenesis. Histologically they are characterized by large, venous-like vascular spaces. Scleroembolization constitutes the most widespread method in the treatment of venous malformations allowing good results with low invasiveness. Currently, Bleomycin (and its derivatives) is among the most widely used sclerosing agents for slow-flowing vascular malformations (venous and lymphatic malformations) because of the low rate of local serious adverse events such as swelling, necrosis, and nerve injury compared with others.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06189092
Study type Observational [Patient Registry]
Source Istituto Ortopedico Rizzoli
Contact
Status Recruiting
Phase
Start date October 28, 2023
Completion date November 28, 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT02384122 - Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias Phase 3
Completed NCT02561182 - Bone Health in Patients With Overgrowth
Active, not recruiting NCT03987152 - Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life Phase 3
Recruiting NCT05113420 - The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations
Completed NCT04637997 - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations N/A
Recruiting NCT02883023 - Electrosclerotherapy for Capillary Malformations Phase 2
Recruiting NCT06160739 - Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
Completed NCT02991352 - Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot Study N/A
Recruiting NCT03972592 - Topical Sirolimus in Cutaneous Lymphatic Malformations Phase 2
Active, not recruiting NCT05418816 - SelfWrap-Assisted Arteriovenous Fistulas N/A
Recruiting NCT04104464 - Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)
Recruiting NCT02638389 - Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care Phase 3
Recruiting NCT03440827 - Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular Malformations N/A
Recruiting NCT05563831 - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Completed NCT00577213 - Diagnosis of Hemangiomas and Vascular Malformations N/A
Recruiting NCT05494710 - Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility Study N/A
Completed NCT01576601 - The Management of Postoperative Craniotomy Pain in Pediatric Patients N/A
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2